Covered recipient · General Payments record
WAJIH ASKAR
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2021–2023
$438.62
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $249.63 | 12 |
| Education | $89.99 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $145.59 | 4 |
| ViiV Healthcare Company | $66.22 | 3 |
| ABBVIE INC. | $45.57 | 2 |
| Melinta Therapeutics, Inc. | $35.76 | 2 |
| PFIZER INC. | $23.63 | 1 |
| Gilead Sciences, Inc. | $22.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $22.84 | 09/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996171803 | CMS |
| AbbVie Inc. | $22.73 | 11/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996171805 | CMS |
| Astellas Pharma US Inc | $25.12 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034499139 | CMS |
| Astellas Pharma US Inc | $89.99 | 10/09/2023 | Education | Undisputed | 01/23/2026 | 1034581505 | CMS |
| Astellas Pharma US Inc | $0.76 | 10/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034615397 | CMS |
| Astellas Pharma US Inc | $29.72 | 10/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034616071 | CMS |
| Gilead Sciences, Inc. | $22.85 | 10/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025712893 | CMS |
| Melinta Therapeutics, LLC | $17.30 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056140405 | CMS |
| Melinta Therapeutics, LLC | $18.46 | 10/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056141661 | CMS |
| PFIZER INC. | $23.63 | 10/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050004483 | CMS |
| ViiV Healthcare Company | $29.53 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001374785 | CMS |
| ViiV Healthcare Company | $23.55 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001374769 | CMS |
| ViiV Healthcare Company | $13.14 | 09/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001374801 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.